Skip to main content
Clinical Trials/NCT04458649
NCT04458649
Recruiting
Not Applicable

Continuous Glucose Monitoring in Infants

University of California, San Diego1 site in 1 country200 target enrollmentOctober 1, 2020

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Neonatal Hypoglycemia
Sponsor
University of California, San Diego
Enrollment
200
Locations
1
Primary Endpoint
Time spent with glucose <40 mg/dL
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

The purpose of this study is to employ continuous glucose monitoring to measure glucose profiles in newborn infants.

Detailed Description

We will place a continuous glucose monitor on the infant within 2 hours of birth and record blood glucose values every 5 minutes via the monitor; in addition, the infant will receive blood glucose checks via heel stick according to the standard hospital glucose monitoring protocol.

Registry
clinicaltrials.gov
Start Date
October 1, 2020
End Date
December 31, 2024
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Dr Jane Kim

Professor of Pediatrics

University of California, San Diego

Eligibility Criteria

Inclusion Criteria

  • Mother at least 18 years of age
  • Infants born either appropriate for gestational age (AGA) or large for gestational age (LGA)
  • Skin fold over superior gluteus area at least 1 inch in thickness as measured by skin calipers

Exclusion Criteria

  • Infants born small for gestational age (SGA)
  • Infant birth weight \<2.5 kg
  • Infant BMI \<10th percentile on Olsen chart
  • Infants born \<38 weeks gestation
  • Infants with concern for intrauterine growth restriction (IUGR) and short femur length based on ultrasound
  • Mother is non-English speaking

Outcomes

Primary Outcomes

Time spent with glucose <40 mg/dL

Time Frame: The device will be worn from about 2 hours after birth until hospital discharge, up to a maximum of 10 days. It will be removed sooner if required for medical care or if the parent requests removal.

The Dexcom continuous glucose monitors measure interstitial fluid glucose values every 5 minutes. Data obtained from the Dexcom tracings will allow us to quantify how much time both infants with no risk for hypoglycemia (defined here as \<40 mg/dL) and those with risk factors for hypoglycemia spend at a blood glucose of \<40 mg/dL.

Study Sites (1)

Loading locations...

Similar Trials